2018 annual financial data
PTC Therapeutics 2018 Operating margin
Direct answer
Operating margin was -43.7%.
Operating income was -115,685,000 USD and net income was -128,081,000 USD.
Operating cash flow was -27,641,000 USD.
Get free PTC Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 264,734,000 USD
- Operating income
- -115,685,000 USD
- Net income
- -128,081,000 USD
- Operating cash flow
- -27,641,000 USD